Inventor · disambiguated record
Shulamit Patashnik
Also filed as: PATASHNIK SHULAMIT
2 granted patents·7 pending applications·30 citations·filing 2002–2014
64Inventor score
Top patents by PatentIndex Score
9 records- 0190US7989473B2Stable laquinimod preparationsTEVA PHARMA·Filed 2007·Granted Aug 2, 2011·21 cites·37 claims
- 0285US8383645B2Stable laquinimod preparationsTEVA PHARMA·Filed 2012·Granted Feb 26, 2013·9 cites·21 claims
- 0364US2015031774A1Rasagiline orally disintegrating compositionsPATASHNIK SHULAMIT·Filed 2014·Application pending·0 cites
- 0459US2009111892A1Rasagiline Orally Disintegrating CompositionsPATASHNIK SHULAMIT·Filed 2005·Application pending·0 cites
- 0555US2012238636A1Rasagiline orally disintegrating compositionsPATASHNIK SHULAMIT·Filed 2011·Application pending·0 cites
- 0648US2011251235A1Stable laquinimod preparationsTEVA PHARMA·Filed 2011·Application pending·0 cites
- 0741US2003147957A1Dual release formulation comprising levodopa ethyl ester and a decarboxylase inhibitor in immediate release layer with levodopa ethyl ester and a decarboxylase inhibitor in a controlled release coreFiled 2002·Application pending·0 cites
- 0838US2006018957A1Pharmaceutical dosage forms including rasagilineLERNER E I·Filed 2005·Application pending·0 cites
- 0933US2003152628A1Dual release formulation comprising levodopa ethyl ester and a decarboxylase inhibitor in an immediate-release layer with levodopa ethyl ester in a controlled release coreFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shulamit Patashnik files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →